These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2555642)
1. Tissue plasminogen activator and plasmin independently decrease human neutrophil activation. Mehta JL; Mehta P; Lawson DL; Herzbrun L Life Sci; 1989; 45(18):1665-9. PubMed ID: 2555642 [TBL] [Abstract][Full Text] [Related]
2. Effect of plasmin, plasminogen activators and a plasmin inhibitor on bovine in vitro embryo production. Papanikolaou T; Amiridis GS; Dimitriadis I; Vainas E; Rekkas CA Reprod Fertil Dev; 2008; 20(2):320-7. PubMed ID: 18255022 [TBL] [Abstract][Full Text] [Related]
3. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator. Penny WF; Ware JA Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814 [TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic properties. Uhl B; Zuchtriegel G; Puhr-Westerheide D; Praetner M; Rehberg M; Fabritius M; Hessenauer M; Holzer M; Khandoga A; Fürst R; Zahler S; Krombach F; Reichel CA Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1495-504. PubMed ID: 24764453 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. Liu JN; Gurewich V J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471 [TBL] [Abstract][Full Text] [Related]
6. Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator. Marder VJ Thromb Res; 2008; 122 Suppl 3(Suppl 3):S9-S15. PubMed ID: 18722003 [TBL] [Abstract][Full Text] [Related]
7. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972 [TBL] [Abstract][Full Text] [Related]
8. Lys- and glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation. Chen LY; Mehta JL Thromb Res; 1994 Jun; 74(6):555-63. PubMed ID: 8091399 [TBL] [Abstract][Full Text] [Related]
9. Characterization of plasmin-induced platelet aggregation. Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893 [TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils. Prescott SM; Zimmerman GA; Seeger AR Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805 [TBL] [Abstract][Full Text] [Related]
11. Enhanced generation of leukotriene B4 and superoxide radical from calcium ionophore (A23187) stimulated human neutrophils after priming with interferon-alpha. Al-Shabanah OA; Mansour MA; Elmazar MM Res Commun Mol Pathol Pharmacol; 1999; 106(1-2):115-28. PubMed ID: 11127803 [TBL] [Abstract][Full Text] [Related]
12. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system. Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694 [TBL] [Abstract][Full Text] [Related]
13. Effects of addition of tissue-type plasminogen activator in in vitro fertilization medium on bovine embryo development and quality. Krania F; Dovolou E; Rekkas CA; Theodosiadou EK; Pappas I; Amiridis GS Reprod Domest Anim; 2015 Feb; 50(1):112-20. PubMed ID: 25405906 [TBL] [Abstract][Full Text] [Related]
14. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis. Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623 [TBL] [Abstract][Full Text] [Related]
15. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a). Lamanuzzi LB; Mtairag el M; Pepe G; Anglés-Cano E Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335 [TBL] [Abstract][Full Text] [Related]
16. t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes. Niego B; Freeman R; Puschmann TB; Turnley AM; Medcalf RL Blood; 2012 May; 119(20):4752-61. PubMed ID: 22262761 [TBL] [Abstract][Full Text] [Related]
17. Regulation of plasminogen binding to neutrophils. Herren T; Burke TA; Jardi M; Felez J; Plow EF Blood; 2001 Feb; 97(4):1070-8. PubMed ID: 11159539 [TBL] [Abstract][Full Text] [Related]
19. Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function. Smith RJ; Sun FF; Bowman BJ; Iden SS; Smith HW; McGuire JC Biochem Biophys Res Commun; 1982 Dec; 109(3):943-9. PubMed ID: 6297495 [No Abstract] [Full Text] [Related]